Ultragenyx Pharmaceutical(DE:UP0)
€15.79+1.06 (+7.20%)
DE:UP0
Ultragenyx Pharmaceutical earnings date
€15.79
At close:+1.06 (+7.20%)
Ultragenyx Pharmaceutical (UP0) Q3 2024 Earnings Report
2 Followers
DE:UP0 Q3 2024 EPS Results
- Actual EPS
- -EUR 1.27
- Consensus EPS
- -EUR 1.35
- Beat/Miss
- Beat by +EUR 0.08
- One Year Ago EPS
- -EUR 2.03
DE:UP0 Q3 2024 Revenue Results
- Actual Revenue
- EUR 126.90M
- Expected Revenue
- EUR 123.07M
- Beat/Miss
- Beat by +EUR 3.83M
- YoY Revenue Growth
- +42.27%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/05/2024
- Time
- After Close
- Conference Call
- Tuesday, November 5, 2024
DE:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
DE:UP0 Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 2.15- | -1.17 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -1.00-1.06 | -1.65 | 35.91% (+0.59) | |
| Aug 04, 2026 | 2026 (Q2) | -1.13-0.82 | -1.06 | 23.08% (+0.25) | |
| May 05, 2026 | 2026 (Q1) | -1.35-1.67 | -1.43 | -17.20% (-0.25) | |
| Feb 12, 2026 | 2025 (Q4) | -0.99-1.17 | -1.26 | 7.19% (+0.09) | |
| Nov 04, 2025 | 2025 (Q3) | -1.12-1.65 | -1.27 | -29.29% (-0.37) | |
| Aug 05, 2025 | 2025 (Q2) | -1.18-1.06 | -1.38 | 23.03% (+0.32) | |
| May 06, 2025 | 2025 (Q1) | -1.45-1.43 | -1.85 | 22.66% (+0.42) | |
| Feb 13, 2025 | 2024 (Q4) | -1.19-1.26 | -1.38 | 8.55% (+0.12) | |
| Nov 05, 2024 | 2024 (Q3) | -1.35-1.27 | -2.03 | 37.22% (+0.76) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


